An endogenous cannabinoid as an endothelium-derived vasorelaxant

Biochemical and Biophysical Research Communications
M D RandallD A Kendall

Abstract

Since the identification of nitric oxide (NO) as an important mediator of endothelium-dependent relaxation, it has become clear that there is an additional endothelial relaxant factor, termed the endothelium-derived hyperpolarizing factor (EDHF). The identity of EDHF has remained elusive, but it is thought to be an arachidonic acid metabolite. We now report that EDHF-mediated relaxations in the rat mesenteric arterial bed are blocked by a highly selective cannabinoid receptor antagonist, SR141716A, consistent with EDHF being a cannabinoid-like substance. Furthermore, in conscious rats,. the NO-independent depressor and regional vasodilator effects of bradykinin were inhibited by SR141716A. The relaxations in the isolated mesentery were accompanied by the accumulation of an arachidonic acid metabolite, which co-eluted on TLC separation with arachidonoylethanolamide (anandamide), an endogenous cannabinoid derived from arachidonate. We further report that anandamide is a potent vasorelaxant in the mesentery, acting via a hyperpolarizing mechanism. These findings suggest that an endogenous cannabinoid is an endothelium-derived vasorelaxant, which may be EDHF.

Citations

Mar 17, 1999·British Journal of Pharmacology·N Niederhoffer, B Szabo
Apr 27, 1999·British Journal of Pharmacology·N Niederhoffer, B Szabo
May 14, 1999·British Journal of Pharmacology·J V MombouliW F Graier
Aug 26, 2000·British Journal of Pharmacology·I Van den Bossche, B Vanheel
Jul 17, 2001·British Journal of Pharmacology·S J StanfordJ A Mitchell
Oct 19, 2001·British Journal of Pharmacology·R WhiteC R Hiley
Mar 5, 1999·Clinical and Experimental Pharmacology & Physiology·C R TriggleW C Cole
Jun 13, 2002·Clinical and Experimental Pharmacology & Physiology·Harold A ColemanHelena C Parkington
Mar 22, 2002·Clinical and Experimental Pharmacology & Physiology·Chris R Triggle, Hong Ding
Aug 27, 2005·Clinical and Experimental Pharmacology & Physiology·Atsunori UedaTadaaki Iwasaki
May 23, 1998·Annual Review of Pharmacology and Toxicology·C C Felder, M Glass
Sep 18, 1997·The Journal of Clinical Investigation·D G DeutschL C Moore
Mar 6, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hikaru Suzuki
Oct 4, 2011·Journal of Pharmacy & Bioallied Sciences·Pedro CunhaFlávio Reis
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sharmila D ChauhanAdrian J Hobbs
Mar 31, 2004·Canadian Journal of Physiology and Pharmacology·Joke Breyne, Bert J Vanheel
Jan 16, 2007·Canadian Journal of Physiology and Pharmacology·Joke BreyneBert Vanheel
Jan 19, 2005·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Yoshio TanakaLigia Toro
Mar 19, 2002·The Journal of Physiology·David HarrisMichael D Randall
Nov 7, 1998·British Journal of Pharmacology·R White, C R Hiley
Jan 10, 1998·British Journal of Pharmacology·P M ZygmuntA H Weston
Jun 26, 2002·Kidney International·Simone GschwendReinhold Kreutz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.